Installed Building Products holder pays $44.9M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Installed Building Products, Inc. reported that Installed Building Systems, Inc. (IBS), a director by deputization, amended a May 2024 forward sale contract on November 16, 2026, tied to 125,000 underlying common shares. Settlement dates moved from November 16–23, 2026, to March 8–14, 2028, and the number of components changed from six to five; the floor and cap prices were also amended. Contract entries report both an acquisition and a disposition of a forward sale contract.
Separately, IBS terminated another forward sale contract covering 225,000 shares, retained ownership of those shares, and paid the buyer $44,853,030. Jeffrey W. Edwards, President, CEO and Chairman, reported direct ownership of 193,803 common shares. The contract securities were held directly by IBS; Edwards disclaimed beneficial ownership except to the extent of his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Forward sale contract (potential obligation to sell) F4, F5, F6, F7, F8, F9, F10, F11 | 125,000 | -- | -- |
| Other | Forward sale contract (potential obligation to sell) F4, F5, F6, F7, F8, F9, F10, F11 | 125,000 | -- | -- |
| Other | Forward sale contract (potential obligation to sell) F4, F5, F12, F11 | 225,000 | -- | -- |
| Holding | Common Stock, $0.01 par value per share | -- | -- | -- |
| Holding | Common Stock, $0.01 par value per share F1 | -- | -- | -- |
| Holding | Common Stock, $0.01 par value per share F2 | -- | -- | -- |
| Holding | Common Stock, $0.01 par value per share F3 | -- | -- | -- |
Footnotes (12)
- F1. These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.
- F2. These securities are held directly by Installed Building Systems, Inc. ("IBS). Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein. IBS and Mr. Edwards remain the beneficial owners of all Pledged Shares, as defined in Footnote 4, reported in Table II to the extent of his or its pecuniary interest therein. Mr. Edwards is the sole beneficial owner of the shares reported in Table I as directly owned.
- F3. These securities are held by a trust for the benefit of one of Mr. Edwards' children. Mr. Edwards disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F4. As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer, and entered into amendments to one of the September 2023 and May 2024 forward sales contracts on August 12, 2025 and the other September 2023 and May 2024 forward sales contracts on March 3, 2026 . In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge.
- F5. (Continued from footnote 4). The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnotes 6 and 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.
- F6. On November 16, 2026, IBS and the buyer entered into a second amendment to one of the May 2024 forward sale contracts (the "May Amendment Agreement"). The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from November 16, 2026 to November 23, 2026 to the new settlement dates from March 8, 2028 through March 14, 2028,
- F7. (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) decreasing the number of components from 6 to 5, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component.
- F8. (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under the May Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $234.0827 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;
- F9. (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $269.1951 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.
- F10. Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from March 8, 2028 through March 14, 2028 under the May Amendment Agreement.
- F11. These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein.
- F12. On November 16, 2026, IBS and the buyer entered into an agreement to terminate one of the November 2023 forward sale contracts (the "November Termination Agreement"), with respect to all 225,000 shares covered under that contract, with IBS retaining ownership of the 225,000 shares. In connection with the November Termination Agreement, IBS made a cash payment of $44,853,030 to the buyer.
Key Figures
Key Terms
prepaid variable forward sale contracts financial
Settlement Price financial
Floor Price financial
Cap Price financial
VWAP financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What changed in IBP's amended May 2024 forward sale contract?
What happened to the other IBP forward sale contract?
AI-generated analysis. How Rhea-AI works. Not financial advice.